decisionhealth Newsletters, Part B News - 2007 Issue 1 (January)
MSP claims exempt from CAP
Subscribe or sign in to view the full article.
Article Overview
This brief coding update summarizes Medicare guidance related to the Competitive Acquisition Program (CAP) and coordination of benefits for Part B injectable drugs. It is relevant to billing and coding staff who handle Medicare claims, especially when another payer is primary or when claims require a specific modifier to indicate the acquisition source used.
Why This Topic Matters
The article helps readers recognize a Medicare claims scenario where CAP-related billing may differ because of primary insurance status. It also highlights that carriers may monitor use of the modifier mentioned in the guidance.
What You Will Learn
- How Medicare guidance addresses CAP-related claims when another insurer is primary
- How coordination of benefits affects Part B injectable drug acquisition
- The general compliance context for a CAP-related modifier on Medicare claims
- What CMS says about carrier oversight of modifier use
Who Should Read This
- Medical coders
- Billing staff
- Revenue cycle professionals
- Medicare claims specialists
- Compliance staff
Modifiers Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com